Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Major Depressive Disorder, Recurrent, UnspecifiedMajor Depressive Disorder, Single Episode, Unspecified
Interventions
DEVICE

H-Coil Deep TMS in combination with SSRIs

The study group will receive DTMS treatment three times a week for four weeks in combination with SSRI medications.

Trial Locations (19)

10021

Neuropharmacology Services, New York

10032

Columbia University / New York State Psychiatric Institute, New York

21205

Johns Hopkins University, Baltimore

29425

Medical Uni. Of South Carolina (MUSC), Charleston

33408

Advanced Mental Health Care Inc. - Juno Beach, Juno Beach

33411

Advanced Mental Health Care Inc. - Royal Palm Beach, Royal Palm Beach

78757

Senior Adults Specialty Research, Austin

90095

University of California (UCLA), Los Angeles

90403

Smart Brain and Health, Santa Monica

95817

UC Davis Center for Mind & Brain, Davis

02478

McLean Hospital - TMS Services, Belmont

03060

Greater Nashua Mental Health Center, Nashua

75390-8898

UT Southwestern Medical Center at Dallas, Dallas

Unknown

Center for Addiction and Mental Health (CAMH), Toronto

Universitätsklinikum Bonn, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Bonn

Klinik für Psychiatrie und Psychotherapie, Ludwig-Maximilians-Universität, Munich

Beer Yaacov Mental Health Center, Be’er Ya‘aqov

Shalvata Mental Health Center, Hod HaSharon

Hadasah Ein-Karem Medical Center, Jerusalem

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Brainsway

INDUSTRY

NCT01361815 - Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI) | Biotech Hunter | Biotech Hunter